한의기반 통합암치료를 통한 재발성 담낭암 환자의 증상 호전 증례보고
A Case Report of Symptom Improvement with Recurrent Gallbladder Cancer Patients Treated with Korean Medicine-based Integrative Cancer Treatment
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: The purpose of this study was to report the improvement effect of symptoms of integrative cancer treatment (ICT) on recurrent gallbladder cancer patients. Methods: A 73-year-old patient with recurrent gallbladder cancer visited the Daejeon Korean Medicine Hospital of Daejeon University East West Cancer Center (EWCC) on February 2022. After the diagnosis of gallbladder cancer, the patient underwent cholecystectomy and relapsed during follow-up. After the operation, the cancer recurred during follow-up, and after radiation treatment, she had been receiving ICT since February 2022. The clinical outcomes were measured by X-ray, computed tomography (CT), laboratory findings, including tumor markers (CEA, CA19-9), and numeric rating scales (NRS). Results: After treatment, abdominal pain was relieved from NRS 5 to 2, and abdominal circumference decreased from 74.5 to 67. During and after treatment, we found neither hepatotoxicity nor nephrotoxicity in the laboratory findings. Conclusion: This case study suggests that ICT may improve symptoms in patients with gallbladder cancer.
Abstract
Objective: The purpose of this study was to report the improvement effect of symptoms of integrative cancer treatment (ICT) on recurrent gallbladder cancer patients. Methods: A 73-year-old patient with recurrent gallbladder cancer visited the Daejeon Korean Medicine Hospital of Daejeon University East West Cancer Center (EWCC) on February 2022. After the diagnosis of gallbladder cancer, the patient underwent cholecystectomy and relapsed during follow-up. After the operation, the cancer recurred during follow-up, and after radiation treatment, she had been receiving ICT since February 2022. The clinical outcomes were measured by X-ray, computed tomography (CT), laboratory findings, including tumor markers (CEA, CA19-9), and numeric rating scales (NRS). Results: After treatment, abdominal pain was relieved from NRS 5 to 2, and abdominal circumference decreased from 74.5 to 67. During and after treatment, we found neither hepatotoxicity nor nephrotoxicity in the laboratory findings. Conclusion: This case study suggests that ICT may improve symptoms in patients with gallbladder cancer.
참고문헌 (24)
- Zhu AX, "Current management of gallbladder carcinoma", Oncologist, 15(2), pp.168~181 (2010)
- Misra S, "Carcinoma of the gallbladder", Lancet Oncol, 4(3), pp.167~176 (2003)
- Bergquist JR, "Adjuvant systemic therapy after resection of node positive gallbladder cancer : time for a well-designed trial", Int J Surg, 52, pp.171~179 (2018)
- Margonis GA, "Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium", HPB(Oxford), 18(11), pp.872~878 (2016)
- 위영준, "Trends in Gallbladder Cancer Incidence and Survival in Korea", Cancer Research and Treatment, 50(4), pp.1444~1451 (2018), 대한암학회
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2020", Cancer Research and Treatment, 52(2), pp.351~358 (2020), 대한암학회
- 김태규, "Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy", Radiation oncology journal, 35(4), pp.359~367 (2017), 대한방사선종양학회
- Margonis GA, "Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium", HPB(Oxford), 18(11), pp.872~878 (2016)
- Rakić M, "Gallbladder cancer", Hepatobiliary Surg Nutr, 3(5), pp.221~226 (2014)
- Han D, "Prognostic factors in patients with gallbladder adenocarcinoma identified using competing-risks analysis : A study of cases in the SEER database", Medicine, 99(31), pp.e21322~ (2020)
- Park BK, "Retrospective cohort analysis for lung cancer patients treated with Wheel Balance Therapy(WBT)", Korean J Orient Int Med, 19(2), pp.45~56 (2009)
- Ma Z, "Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems : a new strategy for antitumor treatment", International Journal of Nanomedicine, 14, pp.2029~2053 (2019)
- Laura M. Stinton, "Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer", Gut and Liver, 6(2), pp.172~187 (2012), 거트앤리버 소화기연관학회협의회[DOI]
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68(6), pp.394~424 (2018)
- Shih SP, "Gallbladder cancer : The role of laparoscopy and radical resection", Ann Surg, 245(6), pp.893~901 (2007)
- Zhu AX, "Current management of gallbladder carcinoma", Oncologist, 15(2), pp.168~181 (2010)
- Benson AB, "Hepatobiliary cancers, version 2", J Natl Compr Canc Netw, 12(8), pp.1152~1182 (2014)
- Stein A, "Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma(ACTICCA-1 trial)-a randomized, multidisciplinary, multinational phase III trial", BMC cancer, 15, pp.564~ (2015)
- Wang W, "Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression", Oncology reports, 26(5), pp.1143~1148 (2011)
- Rho YS, "Complete resolution of metastatic gallbladder cancer after standard Gemcitabine-Cisplatin combination therapy", Cureus, 7(12), pp.e415~ (2015)
- Kang HJ, "Effects of HAD-B1 on the proliferation of A549 cisplatin-resistant lung cancer cells, Molecular Medicine Reports", Mol Med Rep, 17(5), pp.6745~6751 (2018)
- Kang HJ, "Inhibitory effects of HangAmDan-B1(HAD-B1)on A549 lung cancer cell proliferation and tumor growth in a xenograft model", Journal of Scientific Research, 4(7), pp.187~193 (2016)
- Park SW, "The case report about the effect of Injinolyungsangami on the jaundice, Ascites and Edema in Liver Cancer Patient", The journal of Jehan Oriental Medical Academ, 2(1), pp.17~26 (2014)
- Chen Z, "Therapeutic effect of Amomum villosum on inflammatory bowel disease in rats", Frontiers in pharmacology, 9, pp.639~ (2018)